• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAX3 和 SOX10 激活黑色素瘤中的 MET 受体表达。

PAX3 and SOX10 activate MET receptor expression in melanoma.

机构信息

Section of Dermatology, Department of Medicine, University of Chicago, Chicago IL, USA.

出版信息

Pigment Cell Melanoma Res. 2010 Apr;23(2):225-37. doi: 10.1111/j.1755-148X.2010.00667.x. Epub 2010 Jan 22.

DOI:10.1111/j.1755-148X.2010.00667.x
PMID:20067553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2979310/
Abstract

Melanoma is a cancer with a poorly understood molecular pathobiology. We find the transcription factors PAX3, SOX10, MITF, and the tyrosine kinase receptor MET expressed in melanoma cell lines and primary tumors. Analysis for MET expression in primary tumor specimens showed 27/40 (68%) of the samples displayed an increased expression of MET, and this expression was highly correlated with parallel expression of PAX3, SOX10, and MITF. PAX3 and MITF bind to elements in the MET promoter independently, without evidence of either synergistic activation or inhibition. SOX10 does not directly activate the MET gene alone, but can synergistically activate MET expression with either PAX3 or MITF. In melanoma cells, there was evidence of two pathways for PAX3 mediated MET induction: (i) direct activation of the gene, and (ii) indirect regulation through MITF. SK-MEL23 melanoma cells have both of these pathways intact, while SK-MEL28 melanoma cells only have the first pathway. In summary, we find that PAX3, SOX10 and MITF play an active role in melanoma cells by regulating the MET gene. In consequence, MET promotes the melanoma cancer phenotype by promoting migration, invasion, resistance to apoptosis, and tumor cell growth.

摘要

黑色素瘤是一种分子病理生物学机制尚不清楚的癌症。我们在黑色素瘤细胞系和原发肿瘤中发现了转录因子 PAX3、SOX10、MITF 和酪氨酸激酶受体 MET 的表达。对原发肿瘤标本中 MET 表达的分析显示,40 个样本中有 27 个(68%)显示 MET 表达增加,这种表达与 PAX3、SOX10 和 MITF 的平行表达高度相关。PAX3 和 MITF 独立结合 MET 启动子中的元件,没有协同激活或抑制的证据。SOX10 不能单独直接激活 MET 基因,但可以与 PAX3 或 MITF 协同激活 MET 表达。在黑色素瘤细胞中,有证据表明 PAX3 介导的 MET 诱导有两种途径:(i)直接激活基因,(ii)通过 MITF 间接调节。SK-MEL23 黑色素瘤细胞具有这两种途径,而 SK-MEL28 黑色素瘤细胞只有第一种途径。总之,我们发现 PAX3、SOX10 和 MITF 通过调节 MET 基因在黑色素瘤细胞中发挥积极作用。因此,MET 通过促进迁移、侵袭、抗凋亡和肿瘤细胞生长来促进黑色素瘤的癌症表型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/4284ea2d81d7/nihms249658f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/3f40ee96ff5d/nihms249658f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/e75ae0962285/nihms249658f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/1853e67f9226/nihms249658f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/3cd9f76c7e51/nihms249658f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/c49659ec3cf3/nihms249658f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/4284ea2d81d7/nihms249658f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/3f40ee96ff5d/nihms249658f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/e75ae0962285/nihms249658f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/1853e67f9226/nihms249658f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/3cd9f76c7e51/nihms249658f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/c49659ec3cf3/nihms249658f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d9/2979310/4284ea2d81d7/nihms249658f6.jpg

相似文献

1
PAX3 and SOX10 activate MET receptor expression in melanoma.PAX3 和 SOX10 激活黑色素瘤中的 MET 受体表达。
Pigment Cell Melanoma Res. 2010 Apr;23(2):225-37. doi: 10.1111/j.1755-148X.2010.00667.x. Epub 2010 Jan 22.
2
PAX3 and ETS1 synergistically activate MET expression in melanoma cells.PAX3和ETS1协同激活黑色素瘤细胞中的MET表达。
Oncogene. 2015 Sep 17;34(38):4964-74. doi: 10.1038/onc.2014.420. Epub 2014 Dec 22.
3
PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.在转移性黑色素瘤细胞系中敲低PAX3不会降低MITF的表达。
Melanoma Res. 2011 Feb;21(1):24-34. doi: 10.1097/CMR.0b013e328341c7e0.
4
Human melanocytes form a PAX3-expressing melanocyte cluster on Matrigel by the cell migration process.人类黑素细胞通过细胞迁移过程在基质胶上形成表达PAX3的黑素细胞簇。
J Dermatol Sci. 2014 Oct;76(1):60-6. doi: 10.1016/j.jdermsci.2014.07.006. Epub 2014 Jul 23.
5
Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer.Sox10和Pax3发生物理相互作用,以介导一个保守的c-RET增强子的激活。
Hum Mol Genet. 2003 Apr 15;12(8):937-45. doi: 10.1093/hmg/ddg107.
6
Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.SOX10、PAX3和MITF这三个在瓦登伯格综合征中发生改变的基因之间的相互作用。
Hum Mol Genet. 2000 Aug 12;9(13):1907-17. doi: 10.1093/hmg/9.13.1907.
7
Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling.白细胞介素-6受体信号通路介导黑色素瘤B16/F10.9中Pax3下调及黑色素生成的关闭
J Biol Chem. 2002 Apr 26;277(17):15132-41. doi: 10.1074/jbc.M200004200. Epub 2002 Feb 5.
8
Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.瓦登伯革氏综合征中的转录因子层级:SOX10和PAX3对小眼畸形相关转录因子(MITF)表达的调控
Hum Genet. 2000 Jul;107(1):1-6. doi: 10.1007/s004390000328.
9
Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.受时间调控的神经嵴转录因子可区分不同恶性程度和分化程度的神经外胚层肿瘤。
Neoplasia. 2005 Jun;7(6):575-84. doi: 10.1593/neo.04637.
10
Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II.Waardenburg 综合征相关 PAX3 和 SOX10 突变的功能分析:Waardenburg 综合征Ⅱ型中一种显性负性 SOX10 突变的报告。
Hum Genet. 2012 Mar;131(3):491-503. doi: 10.1007/s00439-011-1098-2. Epub 2011 Oct 1.

引用本文的文献

1
PAX3 Regulatory Signatures and Gene Targets in Melanoma Cells.黑色素瘤细胞中的PAX3调控特征与基因靶点
Genes (Basel). 2025 May 14;16(5):577. doi: 10.3390/genes16050577.
2
CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness.癌胚抗原相关细胞黏附分子1(CEACAM1)是SOX10的直接靶点,可抑制黑色素瘤的免疫浸润和干性。
iScience. 2022 Nov 7;25(12):105524. doi: 10.1016/j.isci.2022.105524. eCollection 2022 Dec 22.
3
Downregulation of the paired box gene 3 inhibits the progression of skin cutaneous melanoma by inhibiting c-MET tyrosine kinase : PAX3 downregulation inhibits melanoma progression.配对盒基因 3 的下调通过抑制 c-MET 酪氨酸激酶抑制皮肤黑色素瘤的进展:PAX3 的下调抑制黑色素瘤的进展。
Mol Biol Rep. 2022 Oct;49(10):9137-9145. doi: 10.1007/s11033-022-07706-5. Epub 2022 Sep 4.
4
The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17.转录因子 PAX8 通过与 SOX17 相互作用促进卵巢癌血管生成。
Sci Signal. 2022 Apr 5;15(728):eabm2496. doi: 10.1126/scisignal.abm2496.
5
Resistance to Molecularly Targeted Therapies in Melanoma.黑色素瘤对分子靶向治疗的耐药性
Cancers (Basel). 2021 Mar 5;13(5):1115. doi: 10.3390/cancers13051115.
6
MITF reprograms the extracellular matrix and focal adhesion in melanoma.MITF 重编程黑色素瘤中的细胞外基质和焦点黏附。
Elife. 2021 Jan 13;10:e63093. doi: 10.7554/eLife.63093.
7
BRN2 expression increases anoikis resistance in melanoma.BRN2表达增加黑色素瘤对失巢凋亡的抗性。
Oncogenesis. 2020 Jul 6;9(7):64. doi: 10.1038/s41389-020-00247-1.
8
PAX3 is a biomarker and prognostic factor in melanoma: Database mining.PAX3是黑色素瘤中的一种生物标志物和预后因素:数据库挖掘。
Oncol Lett. 2019 Jun;17(6):4985-4993. doi: 10.3892/ol.2019.10155. Epub 2019 Mar 18.
9
Stem Cell-Derived Models of Neural Crest Are Essential to Understand Melanoma Progression and Therapy Resistance.神经嵴干细胞衍生模型对于理解黑色素瘤进展和治疗耐药性至关重要。
Front Mol Neurosci. 2019 May 1;12:111. doi: 10.3389/fnmol.2019.00111. eCollection 2019.
10
The expression and function of PAX3 in development and disease.PAX3 在发育和疾病中的表达和功能。
Gene. 2018 Aug 5;666:145-157. doi: 10.1016/j.gene.2018.04.087. Epub 2018 May 4.

本文引用的文献

1
PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene.PAX6在胰腺癌中表达,并通过激活MET酪氨酸激酶受体基因积极参与癌症进展。
J Biol Chem. 2009 Oct 2;284(40):27524-32. doi: 10.1074/jbc.M109.047209. Epub 2009 Aug 3.
2
Melanoma epidemiology and trends.黑色素瘤流行病学与趋势。
Clin Dermatol. 2009 Jan-Feb;27(1):3-9. doi: 10.1016/j.clindermatol.2008.09.001.
3
Inhibition of PAX3 by TGF-beta modulates melanocyte viability.转化生长因子-β对PAX3的抑制作用可调节黑素细胞的活力。
Mol Cell. 2008 Nov 21;32(4):554-63. doi: 10.1016/j.molcel.2008.11.002.
4
Sox10: a pan-schwannian and melanocytic marker.Sox10:一种泛施万细胞和黑素细胞标志物。
Am J Surg Pathol. 2008 Sep;32(9):1291-8. doi: 10.1097/PAS.0b013e3181658c14.
5
PAX3 expression in primary melanomas and nevi.PAX3在原发性黑色素瘤和痣中的表达。
Mod Pathol. 2008 May;21(5):525-30. doi: 10.1038/modpathol.3801019. Epub 2008 Mar 7.
6
The Met tyrosine kinase receptor in development and cancer.发育与癌症中的Met酪氨酸激酶受体
Cancer Metastasis Rev. 2008 Mar;27(1):85-94. doi: 10.1007/s10555-007-9107-6.
7
c-Met must translocate to the nucleus to initiate calcium signals.c-Met必须转移至细胞核以启动钙信号。
J Biol Chem. 2008 Feb 15;283(7):4344-51. doi: 10.1074/jbc.M706550200. Epub 2007 Dec 11.
8
c-Met is a potentially new therapeutic target for treatment of human melanoma.c-Met是治疗人类黑色素瘤的一个潜在新治疗靶点。
Clin Cancer Res. 2007 Apr 1;13(7):2246-53. doi: 10.1158/1078-0432.CCR-06-0776.
9
Up-regulation of MET expression by alpha-melanocyte-stimulating hormone and MITF allows hepatocyte growth factor to protect melanocytes and melanoma cells from apoptosis.α-黑素细胞刺激素和小眼畸形相关转录因子对MET表达的上调作用,使得肝细胞生长因子能够保护黑素细胞和黑色素瘤细胞免于凋亡。
J Biol Chem. 2007 May 11;282(19):14140-7. doi: 10.1074/jbc.M611563200. Epub 2007 Mar 19.
10
Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density.肝细胞生长因子受体Met在低密度细胞中定位于细胞核。
Cancer Res. 2006 Aug 15;66(16):7976-82. doi: 10.1158/0008-5472.CAN-05-4335.